Session 031: Pharmacy Pricing - US Policy and Global Perspectiveprocurement that currently serves all public health care stakeholders • This resulted in cumulative savings ... Calmette–Guérin vaccine, botulinum and diphtheria antitoxins, direct- acting antiretrovirals for hepatitis C, pandemic ...
Description: US pharmacy prices have entered a new era of growth driven by Specialty medications. A bevy of state and national regulations have been proposed to address pharmacy pricing, industry structure and transparency.Health actuaries will learn about US pharmacy pricing structure and how proposed legislation could affect future costs. Actuaries that have responsibility for pharmacy rate/budget setting, RFPs or trend projection will benefit from a deeper understanding of the US pharmacy market landscape and gain an international perspective.Hide
- Authors: Gregory L Warren, Laura Elizabeth Coe , Scott Fry
- Date: May 2019
- Competency: External Forces & Industry Knowledge
- Topics: Health & Disability>Payment models; Public Policy